Company Monitoring Page for Roche

latest headlines for company on cafepharma

Pacific Biosciences Rockets on Roche Diagnostics Deal
Motley Fool
Wed, 09/25/13 - 01:11 pm
Tags:
Roche, diagnostics, Pacific Biosciences
A Novartis -- Roche Merger? Say It Isn't So!
Forbes
Tue, 09/24/13 - 10:14 am
Tags:
Novartis, Roche, M&A
The Pharmaceutical Industry's 10 Biggest R&D Budgets
Motley Fool
Mon, 09/23/13 - 12:02 pm
Tags:
R&D, Roche, Pfizer, Merck, JNJ, Novartis, Sanofi, GSK, Eli Lilly, AstraZeneca, Bristol-Myers Squibb
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Tags:
Europe, drug approvals, Kadcyla, Roche, Bayer, Xofigo, Abilify Maintena, Otsuka, Lundbeck, Memantine Accord, Accord Healthcare, Levodopa Carbidopa Entacapone Sandoz, Orion, Vitekta, Gilead, Janssen-Cilag, Invokana, Novo Nordisk, NovoEight, AstraZeneca, Fluenz Tetra, GSK, Relvar Ellipta, Lidocaine/Prilocaine Plethora, Plethora Solutions
Novartis board member suggests Roche merger
Independent.ie, Ireland
Mon, 09/23/13 - 09:25 am
Tags:
Novartis, M&A, Roche
BioMarin's Buyout False Start Leads Biotech's Record Surge
Motley Fool
Sun, 09/22/13 - 11:32 am
Tags:
Biomarin, Roche
Roche CEO Says Drugmaker Isn’t Seeking Financing for Deal
Bloomberg
Fri, 09/20/13 - 09:53 am
Tags:
Roche, Pharma CEOs, Severin Schwan, M&A, Biomarin
Is Roche a Small Biotech's Best Friend?
Motley Fool
Thu, 09/19/13 - 03:01 am
Tags:
Roche, Inovio, Curis
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
Tags:
chronic lymphocytic leukemia, Sanofi, Campath, GSK, Arzerra, Roche, Rituxan, ibrutinib, Pharmacyclics, obinutuzumab, JNJ, Genmab
Aging population to fuel big leap in cancer cases--and drug sales
Fierce Pharma
Tue, 09/17/13 - 12:36 pm
Tags:
cancer, aging, Roche, Celgene, GSK, Novartis, Pfizer, Bayer
FDA approves Teva's generic version of Roche cancer drug Xeloda
Reuters
Mon, 09/16/13 - 03:46 pm
Tags:
generics, Teva, FDA, Roche, Xeloda, breast cancer, colorectal cancer
Lufthansa CEO Franz Quits in Surprise Move to Roche
Bloomberg
Mon, 09/16/13 - 11:13 am
Tags:
Roche, Pharma CEOs, Christoph Franz
Roche Perjeta Wins Panel Backing for Early Breast Cancer
Bloomberg
Fri, 09/13/13 - 08:42 am
Tags:
Roche, Perjeta, breast cancer, FDA, advisory panels
Pharma chief casts doubt on Roche interest in Alexion
Fierce Pharma
Thu, 09/12/13 - 10:30 am
Tags:
Alexion, Roche, M&A, Daniel O'Day
Can Stopping This Hedgehog Create New Cancer Treatments?
Motley Fool
Tue, 09/10/13 - 11:30 am
Tags:
hedgehog pathway inhibitor, Curis, Roche, basal cell carcinoma, Erivedge
FDA scientists back accelerated approval for Roche drug to treat early-stage breast cancer
Washington Post, DC
Tue, 09/10/13 - 10:39 am
Tags:
Perjeta, FDA, Roche, breast cancer
Bristol Myers: A Leader In Cancer Care
Seeking Alpha
Fri, 08/30/13 - 08:46 am
Tags:
Bristol-Myers Squibb, Merck, Gilead, Pfizer, Roche
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
Tags:
monoclonal antibodies, Roche, Herceptin, Rituxan, Avastin, GSK, Amgen, Eli Lilly, Bristol-Myers Squibb, Seattle Genetics, Adcetris, Kadcyla, bapineuzumab, Elan, JNJ, Pfizer, necitumumab, AbbVie, Humira
Roche looks to replicate cancer success with eye drugs
Reuters
Tue, 08/27/13 - 05:40 pm
Tags:
Roche, lamp, lampalizumab, dry AMD
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
Tags:
JNJ, Novartis, Pfizer, Merck, Roche, Bayer, Sanofi, GSK, Abbott Labs, AstraZeneca, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.